After Hours
$
33.82
Change
0.00 0.00%
Volume
Volume 25,226
Aug 12, 2022, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 32.65
$ 33.82
Change
+1.17 +3.58%
Day low
Day high
$32.85
$35.19

52 week low
52 week high
$17.10
$91.90

Market cap
$3.28B
Average volume
1.60M
P/E ratio
N/A
Rev. per Employee
$152,016
EPS
-2.64
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on FATE
-
The Bull Market in Biotech Is Still Going Strong
- Barron's Online
-
25 Stocks That Could Rise on a Short Squeeze
- Barron's Online
-
Canoo and 4 More EV Stocks Are at Risk of a 'Short Squeeze.' Beware.
- Barron's Online
-
Fate Therapeutics upgraded to outperform from market perform at BMO Capital
- Tomi Kilgore
-
Fate Therapeutics stock price target cut to $51 from $75 at Truist
- Tomi Kilgore
-
Fate Therapeutics stock price target cut to $75 from $125 at Truist
- Tomi Kilgore
-
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, outperforms market
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For March 6, 2018
- Benzinga.com
Other News on FATE
-
- Edgar Online - (EDG = 10Q, 10K)
-
Warning: FATE is at high risk of performing badly
- Seeking Alpha
-
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2022 Update
- Seeking Alpha
-
Warning: FATE is at high risk of performing badly
- Seeking Alpha
-
Trial Results Set to Make or Break Small-Cap Pharma Stocks
- GuruFocus.com
-
Fate, Ono expand team up on cancer immunotherapy program
- Seeking Alpha
-
I-Mab Valuation Offers A Biotech Investment Opportunity
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
Press Releases on FATE
-
Tuesday's ETF Movers: ARKK, OIH
- MarketNewsVideo.com
-
Friday's ETF Movers: SIL, ARKK
- MarketNewsVideo.com
-
Onxeo Appoints Dr. Shefali Agarwal as President and Chief Executive Officer
- BusinessWire - BZX
-
Monday's ETF Movers: PSI, ARKG
- MarketNewsVideo.com
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com